Powered by

Senseonics Announces a Positive Coverage Decision for Eversense CGM from Health Care Service Corporation - Blue Cross Blue Shield of Illinois, Montana, New Mexico, Oklahoma and Texas; --HCSC coverage decision adds more than 16 million covered lives for Ev

Oct 14, 2019 - Business Wire

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that Health Care Service Corporation (HCSC) - Blue Cross Blue Shield is now providing coverage for the Eversense CGM System, effective October 15, 2019. This recent coverage decision adds to the growing number of payers who are writing Eversense into...